PNLIP and obesity due to melanocortin 4 receptor deficiency: De facto, many studies reported that the mechanism of action of the EOs as anti-obesity agents may be attributed to several possible factors such as their ability to suppress the effect of pancreatic lipase enzyme, increase the glycerol level in the plasma, or inhibit the accumulation of fats in the human body [6,7].